GSK (NYSE) - GlaxoSmithKline PLC ADR
Exchange: USA Stocks • Country: USA • Currency: USD • Type: Common Stock • ISIN: US37733W1053
GSK plc, together with its subsidiaries, engages in the research, development and manufacture of vaccines and specialty medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as infectious disease, HIV, immunology and respiratory, and oncology. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is based in Brentford, the United Kingdom. Web URL: https://www.gsk.com
Drawdown (Underwater) Chart
External Links for GSK (NYSE) - GlaxoSmithKline PLC ADR
| Market Cap. | 72,767m USD |
| Enterprise Value | 90,782m USD (+24%) |
| GiC Sector | Health Care |
| GiC Group | Pharmaceuticals, Biotechnology & Life Sciences |
| GiC Industry | Pharmaceuticals |
| GiC SubIndustry | Pharmaceuticals |
| TER | 0.00% |
| IPO / Inception | 1986-07-09 |
Ratings
| Fundamental | 3.75 |
| Dividend | 6.42 |
| Technical | 1.13 |
| Performance | -2.16 |
| Analysts | 3.00 |
| Price / Fair Price TR | 1.15 |
| Price / Fair Price DCF | todo |
Technical
| Growth TTM | -21.22% |
| CAGR 5y | 1.44% |
| CAGR / Mean Drawdown 5y | 0.13 |
| Sharpe Ratio TTM | -1.03 |
| Alpha vs SP500 TTM | -24.28 |
| Beta vs SP500 5y weekly | 0.57 |
| Volatility GJR Garch 1y | 20.45% |
| CAPM | 7.74% |
| Correlation TTM | 0.01 |
| Max Drawdown 5y | 39% |
| Mean Drawdown 5y | 11.1% |
| Price / SMA 200 days | -1.93% |
| Current Volume | 2207.7k |
| Average Volume | 2866k |
Dividends
| Rate TTM | 1.38 |
| Yield TTM | 4.02% |
| Div. CAGR 5y | -5.08% |
| Consistency of Dividends all time | 94.2% |